検索
Quanterix Corp
QTRXウォッチリストに追加
4.330USD
-0.010-0.23%
終値 07/02, 13:00（ET）15分遅れの株価
203.77M時価総額
損失額直近12ヶ月PER
詳細情報 Quanterix Corp 企業名
Quanterix Corporation is engaged in fueling scientific discovery through ultra-sensitive biomarker detection. The Company’s Simoa technology delivers earlier biomarker detection in blood, serum or plasma, with the ability to quantify proteins that are far lower than the level of quantification (LoQ). Its precision instruments, digital immunoassay technology and CLIA-certified Accelerator laboratory have supported research that advances disease understanding and management in neurology, oncology, immunology, cardiology and infectious disease. Its products and services include Simoa Assay Kits, Simoa Dry Blood Extraction Kit, LDTs & Assay Services, Instruments, Simoa Accelerator Laboratory, Homebrew-Custom Assay Development, and Nova Beads. LDTs & Assay Services include Simoa p-Tau 217, Simoa NfL LDT, and LucentAD pTau 217. Its instruments include Simoa HD-X Analyzer-Automated Immunoassays, Quanterix SR-X Biomarker Detection System, and SP-X Imaging and Analysis System.
Quanterix Corpの企業情報
企業コードQTRX
会社名Quanterix Corp
上場日Dec 07, 2017
最高経営責任者「CEO」Toloue (Masoud)
従業員数471
証券種類Ordinary Share
決算期末Dec 07
本社所在地900 Middlesex Turnpike
都市BILLERICA
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号01821
電話番号16173019400
ウェブサイトhttps://www.quanterix.com/
企業コードQTRX
上場日Dec 07, 2017
最高経営責任者「CEO」Toloue (Masoud)
Quanterix Corpの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Masoud Toloue, Ph.D.
Dr. Masoud Toloue, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
355.02K
+20.48%
Mr. William P. (Bill) Donnelly
Mr. William P. (Bill) Donnelly
Executive Chairman of the Board
Executive Chairman of the Board
154.13K
+8.83%
Ms. Vandana Sriram, CPA
Ms. Vandana Sriram, CPA
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
34.95K
+3.68%
Ms. Karen A. Flynn
Ms. Karen A. Flynn
Independent Director
Independent Director
33.84K
-47.10%
Mr. Scott Mendel
Mr. Scott Mendel
Director
Director
12.35K
-155.84%
Mr. Jeffrey Thomas (Jeff) Elliott
Mr. Jeffrey Thomas (Jeff) Elliott
Lead Independent Director
Lead Independent Director
11.39K
-139.92%
Dr. Myla P. Lai-Goldman, M.D.
Dr. Myla P. Lai-Goldman, M.D.
Director
Director
6.97K
-335.42%
Dr. Ivana Magov Evi-liebisch, J.D., Ph.D.
Dr. Ivana Magov Evi-liebisch, J.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Garret Hampton, Ph.D.
Dr. Garret Hampton, Ph.D.
Independent Director
Independent Director
--
--
Dr. Alan Sachs, M.D., Ph.D.
Dr. Alan Sachs, M.D., Ph.D.
Independent Director
Independent Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Masoud Toloue, Ph.D.
Dr. Masoud Toloue, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
355.02K
+20.48%
Mr. William P. (Bill) Donnelly
Mr. William P. (Bill) Donnelly
Executive Chairman of the Board
Executive Chairman of the Board
154.13K
+8.83%
Ms. Vandana Sriram, CPA
Ms. Vandana Sriram, CPA
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
34.95K
+3.68%
Ms. Karen A. Flynn
Ms. Karen A. Flynn
Independent Director
Independent Director
33.84K
-47.10%
Mr. Scott Mendel
Mr. Scott Mendel
Director
Director
12.35K
-155.84%
Mr. Jeffrey Thomas (Jeff) Elliott
Mr. Jeffrey Thomas (Jeff) Elliott
Lead Independent Director
Lead Independent Director
11.39K
-139.92%
よくある質問
Quanterix Corpの上位5名の株主は誰ですか？
Quanterix Corpの上位5名の株主は以下のとおりです。Dr. Masoud Toloue, Ph.D.
Quanterix Corp（QTRX）の株式を保有している機関の数はいくつですか？
2026Q1時点で、Quanterix Corpの株式を保有している機関は371社あり、保有株式の総市場価値は約42.63Mで、全体の90.49%を占めています。2025Q4と比較して、機関の持ち株は-4982326.00増加しています。
Quanterix Corpの最大の収益源は何ですか？
2026Q1において、Product revenue部門がQuanterix Corpにとって最大の収益を生み出しており、その金額は92.94Mで、全収益の67.03%を占めています。